drugset / Trial / NCT00492232
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess whether ramelteon, once daily (QD), can facilitate the discontinuation of zolpidem in subjects with chronic insomnia.
Timeline
- Start
- 2007-04
- Primary completion
- 2008-03
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ramelteon | Unknown | 8 mg | Oral |
| Subject | Zolpidem | Small molecule | — | — |